COVID-19 — South Africa
South Africa recently received 1 million doses of AstraZeneca-Oxford COVID-19 vaccine and was poised to start vaccinating healthcare workers, but yesterday [7 Feb 2021], health officials announced a pause for the rollout to investigate early findings that it offered little protection against mild-to-moderate disease caused by variant 501Y.V2, lineage B.1.351 that’s dominant in the country.
New questions about the vaccine come as World Health Organization (WHO) advisers this week consider it
…
